期刊文献+

存活蛋白重组腺病毒载体的构建及其在树突状细胞的表达 被引量:2

Construction of Recombinant Adenovirus Vector Containing Human Survivin Gene and Its Expression in Dentritic Cells
下载PDF
导出
摘要 本研究旨在构建含有人存活蛋白(survivin)基因的重组腺病毒载体,并探讨其在转染树突状细胞中的表达。以质粒pcDNA3.0-survivin为模板,通过PCR扩增获得survivin基因全长序列。PCR产物回收后经酶切,定向插入腺病毒穿梭质粒,获得重组质粒pShuttle-CMV-survivin。通过双酶切、PCR及插入片段测序鉴定后,将正确重组体pShuttle-CMV-survivin转化E.coliBJ5183菌(含腺病毒骨架质粒)并进行同源重组,然后筛选阳性克隆,提取质粒,将此重组腺病毒质粒分别进行酶切、线性化、纯化,用脂质体LipofectamineTM2000介导转染293细胞。制备病毒上清并测定其滴度,将病毒上清转染树突状细胞,应用Westernblot方法分析survivin的表达。结果表明成功构建了含有人survivin基因的重组腺病毒,病毒滴度为2.65×109pfu/ml。Westernblot鉴定显示,经重组腺病毒转染的DC可有效表达survivin。结论含survivin基因的重组腺病毒载体的构建成功,为下一步开展抗白血病免疫研究奠定实验基础。 The study was aimed to construct the recombinant adenovirus vectors containing human survivin gene, and to investigate their expression in transfected dentritic cells. Full length cDNA encoding survivin was obtained by PCR amplification from plasmid pcDNA3.0-survivin. The PCR product was restricted, and then inserted into pShuttle-CMV. The plasmids of pShuttle-CMV-survivin were linearized with Pine Ⅰ , and the fragment containing survivin was ligated with pShuttle-CMV and transfected into E. coli BJ5183. After homologous recombination in bacteria, the extracted plasmid from the positive bacteria were linearized with Pac Ⅰ , transfected into HEK293 cells with liposome LipofectamineTM 2000. Then, the harvested adenovirus supernatants were transfected into dendritic cells. The results showed that the recombinant adenovirus-survivin was constructed successfully and its titer was about 2.65 × 10^9 pfu/ml. The expression of survivin in transfected dentritic cells was confirmed by Western blot analysis. It is concluded that the recombinant adenovirus vector containing human survivin was constructed successfully, which may provide preliminary laboratory evidence for anti-leukemia immunotherapy.
出处 《中国实验血液学杂志》 CAS CSCD 2006年第4期791-794,共4页 Journal of Experimental Hematology
关键词 腺病毒载体 存活蛋白基因 树突状细胞 adenovirus vector survivin gene dendritic cell
  • 相关文献

参考文献11

  • 1Nasz I,Adam E.Recombinant adenovirus vectors for gene therapy and clinical trials.Acta Microbiol Immunol Hung,2001;48:323-348
  • 2Mizuguchi H,Kay MA,Hayakawa T.Approaches for generating recombinant adenovirus vectors.Adv Drug Deliv Rev,2001;52:165-176
  • 3Danthinne X,Imperiale MJ.Production of first generation adenovirus vectors:a review.Gene Ther,2000;7:1707-1714
  • 4Pisarev V,Yu B,Salup R,et al.Full-length dominant-negative survivin for cancer immunotherapy.Clin Cancer Res,2003;9:6523-6533
  • 5Nikitina EY,Chada S,Muro-Cacho C,et al.An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wildtype p53.Gene Ther,2002;9:345-352
  • 6Okada N,Masunaga Y,Okada Y,et al.Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors.Cancer Gene Ther,2003;10:421-431
  • 7Herrera OB,Brett S,Lechler RI.Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectorsleads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.Vaccine,2002;21:231-242
  • 8Tsang KY,Zhu M,Even J,et al.The infection of human dendritic cels with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells.Cancer Res,2001;61:7568-7576
  • 9Rea D,Havenga MJ,van-Den-Assent M,et al.Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.J Immunol,2001;166:5236-5244
  • 10Meyer-zum-Buschenfelde C,Nicklisch N,Rose-John S,et al.Ge-neration of tumor-reactive CTL against the tumor-associated antigen HER2 using retroviraly transduced dendritic cells derived from CD34+ hemopoietic progenitor cells.J Immunol,2000;165:4133-4140

同被引文献12

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部